![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Browner C H, Preloran H M. Male partners' role in Latinas' amniocentesis decision. Journal of Genetic Counselling 1999; 8: 85–108
- Browner C H, Preloran H M, Cox S J. Ethnicity, bioethics and prenatal diagnosis: The amniocentesis decisions of Mexican-origin women and their partners. American Journal of Public Health 1999; 89: 1658–1666
- Browner C H, Preloran H M, Casado M C, Bass N B, Walker A P. Genetic counselling gone awry: miscommunication between prenatal genetic service providers and Mexican-origin clients. Social Science and Medicine 2003; 56: 1933–1946
- Dormandy E, Marteau T M. Uptake of prenatal screening test: The role of the healthcare professionals' attitudes towards the test. Prenatal Diagnosis 2004; 24: 851–942
- Green J M. Serum screening for Down's syndrome: experiences of obstetricians in England and Wales. British Medical Journal 1994; 309: 769–772
- Nicolaides K H, Chervenak F A, McCullough L B, Avgidou K, Papageorghiou A. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first trimester assessment of risk for trisomy 21. American Journal of Obstetrics and Gynaecology 2005; 193: 322–326
- Round A, Hamilton W. Prenatal screening for Down's syndrome (comment). British Medical Journal 1993; 307: 1211–1212
- Smith D K, Shaw R W, Marteau T M. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. British Medical Journal 1994; 309: 776
- UK National Screening Committee. Antenatal Screening Service for Down's syndrome in England: 2001. A Report to the National Screening Committee. National Screening Committee Programme Directorate, London 2002; 36–37